Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49


Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.

Guo CC, Majewski T, Zhang L, Yao H, Bondaruk J, Wang Y, Zhang S, Wang Z, Lee JG, Lee S, Cogdell D, Zhang M, Wei P, Grossman HB, Kamat A, Duplisea JJ, Ferguson JE 3rd, Huang H, Dadhania V, Gao J, Dinney C, Weinstein JN, Baggerly K, McConkey D, Czerniak B.

Cell Rep. 2019 May 7;27(6):1781-1793.e4. doi: 10.1016/j.celrep.2019.04.048.


Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.

Majewski T, Yao H, Bondaruk J, Chung W, Lee S, Lee JG, Zhang S, Cogdell D, Yang G, Choi W, Dinney C, Grossman HB, Logothetis C, Scherer SE, Guo CC, Zhang L, Wei P, Weinstein JN, Issa JP, Baggerly K, McConkey DJ, Czerniak B.

Cell Rep. 2019 Feb 19;26(8):2241-2256.e4. doi: 10.1016/j.celrep.2019.01.095.


Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.

Zhang S, Wang Y, Bondaruk J, Majewski T, Yao H, Lee S, Lee JG, Cogdell D, Lotan Y, Dinney C, Wei P, Baggerly K, Czerniak B.

Eur Urol Focus. 2019 Jul;5(4):664-675. doi: 10.1016/j.euf.2018.01.017. Epub 2018 Feb 7.


Erratum to: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.

Wang Y, Hu L, Ji P, Teng F, Tian W, Liu Y, Cogdell D, Liu J, Sood AK, Broaddus R, Xue F, Zhang W.

J Hematol Oncol. 2017 Oct 6;10(1):163. doi: 10.1186/s13045-017-0525-9. No abstract available.


MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway.

Sun L, Hu L, Cogdell D, Lu L, Gao C, Tian W, Zhang Z, Kang Y, Fleming JB, Zhang W.

Autophagy. 2017 Apr 3;13(4):703-714. doi: 10.1080/15548627.2017.1280217. Epub 2017 Jan 25.


Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.

Dadhania V, Zhang M, Zhang L, Bondaruk J, Majewski T, Siefker-Radtke A, Guo CC, Dinney C, Cogdell DE, Zhang S, Lee S, Lee JG, Weinstein JN, Baggerly K, McConkey D, Czerniak B.

EBioMedicine. 2016 Oct;12:105-117. doi: 10.1016/j.ebiom.2016.08.036. Epub 2016 Aug 25.


MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.

Wang Y, Hu L, Ji P, Teng F, Tian W, Liu Y, Cogdell D, Liu J, Sood AK, Broaddus R, Xue F, Zhang W.

J Hematol Oncol. 2016 Oct 19;9(1):112. doi: 10.1186/s13045-016-0342-6. Erratum in: J Hematol Oncol. 2017 Oct 6;10 (1):163.


ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy.

Yasukawa M, Liu Y, Hu L, Cogdell D, Gharpure KM, Pradeep S, Nagaraja AS, Sood AK, Zhang W.

Oncotarget. 2016 Aug 8;8(51):88410-88420. doi: 10.18632/oncotarget.11120. eCollection 2017 Oct 24.


Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies.

Phillips LM, Zhou X, Cogdell DE, Chua CY, Huisinga A, R Hess K, Fuller GN, Zhang W.

J Pathol. 2016 Jul;239(3):355-64. doi: 10.1002/path.4734. Epub 2016 Jun 10.


Examining plasma microRNA markers for colorectal cancer at different stages.

Sun Y, Liu Y, Cogdell D, Calin GA, Sun B, Kopetz S, Hamilton SR, Zhang W.

Oncotarget. 2016 Mar 8;7(10):11434-49. doi: 10.18632/oncotarget.7196.


Accuracy of EasyChip HPV blot genotyping assay to detect high-risk HPV genotypes in SurePath Papanicolaou specimens.

Amy Chen YJ, Lin CY, Feng J, Cogdell D, Zhang W, Liu J, Sneige N, Gong Y, Guo M.

J Am Soc Cytopathol. 2016 Nov - Dec;5(6):351-358. doi: 10.1016/j.jasc.2016.06.001. Epub 2016 Jun 27.


Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.

Liu G, Yang D, Rupaimoole R, Pecot CV, Sun Y, Mangala LS, Li X, Ji P, Cogdell D, Hu L, Wang Y, Rodriguez-Aguayo C, Lopez-Berestein G, Shmulevich I, De Cecco L, Chen K, Mezzanzanica D, Xue F, Sood AK, Zhang W.

J Natl Cancer Inst. 2015 May 20;107(7). pii: djv108. doi: 10.1093/jnci/djv108. Print 2015 Jul. Erratum in: J Natl Cancer Inst. 2017 Nov 1;109(11):. J Natl Cancer Inst. 2019 Nov 1;111(11):1240.


IGFBP2 potentiates nuclear EGFR-STAT3 signaling.

Chua CY, Liu Y, Granberg KJ, Hu L, Haapasalo H, Annala MJ, Cogdell DE, Verploegen M, Moore LM, Fuller GN, Nykter M, Cavenee WK, Zhang W.

Oncogene. 2016 Feb 11;35(6):738-47. doi: 10.1038/onc.2015.131. Epub 2015 Apr 20.


Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.

Turner KM, Sun Y, Ji P, Granberg KJ, Bernard B, Hu L, Cogdell DE, Zhou X, Yli-Harja O, Nykter M, Shmulevich I, Yung WK, Fuller GN, Zhang W.

Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3421-6. doi: 10.1073/pnas.1414573112. Epub 2015 Mar 3.


MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.

Guo F, Cogdell D, Hu L, Yang D, Sood AK, Xue F, Zhang W.

Oncol Rep. 2014 May;31(5):2021-8. doi: 10.3892/or.2014.3106. Epub 2014 Mar 21.


MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer.

Liu G, Sun Y, Ji P, Li X, Cogdell D, Yang D, Parker Kerrigan BC, Shmulevich I, Chen K, Sood AK, Xue F, Zhang W.

J Pathol. 2014 Jul;233(3):308-18. doi: 10.1002/path.4348. Epub 2014 May 21. Erratum in: J Pathol. 2019 Oct;249(2):268.


Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.

Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, Zhao Y, Reynolds S, Cheng H, Rupaimoole R, Cogdell D, Nykter M, Broaddus R, Rodriguez-Aguayo C, Lopez-Berestein G, Liu J, Shmulevich I, Sood AK, Chen K, Zhang W.

Cancer Cell. 2013 Feb 11;23(2):186-99. doi: 10.1016/j.ccr.2012.12.020. Erratum in: Cancer Cell. 2013 May 13;23(5):705.


The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.

Parker BC, Annala MJ, Cogdell DE, Granberg KJ, Sun Y, Ji P, Li X, Gumin J, Zheng H, Hu L, Yli-Harja O, Haapasalo H, Visakorpi T, Liu X, Liu CG, Sawaya R, Fuller GN, Chen K, Lang FF, Nykter M, Zhang W.

J Clin Invest. 2013 Feb;123(2):855-65. doi: 10.1172/JCI67144. Epub 2013 Jan 9.


Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma.

Moore LM, Kivinen V, Liu Y, Annala M, Cogdell D, Liu X, Liu CG, Sawaya R, Yli-Harja O, Shmulevich I, Fuller GN, Zhang W, Nykter M.

J Pathol. 2013 Feb;229(3):449-59. doi: 10.1002/path.4109.


[Expression of PRUNE2 mRNA and its positive correlation with non-coding RNA PCA3 in leiomyosarcoma].

Yang JL, Cogdell D, Eddy J, Trent J, Price N, Zhang W.

Zhonghua Zhong Liu Za Zhi. 2012 Jul;34(7):497-500. doi: 10.3760/cma.j.issn.0253-3766.2012.07.005. Chinese.


Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.

Naguib M, Xu JJ, Diaz P, Brown DL, Cogdell D, Bie B, Hu J, Craig S, Hittelman WN.

Anesth Analg. 2012 May;114(5):1104-20. doi: 10.1213/ANE.0b013e31824b0191. Epub 2012 Mar 5.


Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer.

Sircar K, Huang H, Hu L, Liu Y, Dhillon J, Cogdell D, Aprikian A, Efstathiou E, Navone N, Troncoso P, Zhang W.

PLoS One. 2012;7(2):e31259. doi: 10.1371/journal.pone.0031259. Epub 2012 Feb 17.


Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network.

Holmes KM, Annala M, Chua CY, Dunlap SM, Liu Y, Hugen N, Moore LM, Cogdell D, Hu L, Nykter M, Hess K, Fuller GN, Zhang W.

Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3475-80. doi: 10.1073/pnas.1120375109. Epub 2012 Feb 15.


Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer.

Sircar K, Huang H, Hu L, Cogdell D, Dhillon J, Tzelepi V, Efstathiou E, Koumakpayi IH, Saad F, Luo D, Bismar TA, Aparicio A, Troncoso P, Navone N, Zhang W.

Am J Pathol. 2012 Mar;180(3):895-903. doi: 10.1016/j.ajpath.2011.11.030. Epub 2012 Jan 11.


Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.

Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR, Zhang W.

PLoS One. 2011 Mar 17;6(3):e17745. doi: 10.1371/journal.pone.0017745.


Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug.

Yang J, Eddy JA, Pan Y, Hategan A, Tabus I, Wang Y, Cogdell D, Price ND, Pollock RE, Lazar AJ, Hunt KK, Trent JC, Zhang W.

Mol Cell Proteomics. 2010 Nov;9(11):2405-13. doi: 10.1074/mcp.M110.000240. Epub 2010 Jul 22.


Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma.

Wang Y, Yang D, Cogdell D, Hu L, Xue F, Broaddus R, Zhang W.

Technol Cancer Res Treat. 2010 Apr;9(2):179-89.


APEX1 gene amplification and its protein overexpression in osteosarcoma: correlation with recurrence, metastasis, and survival.

Yang J, Yang D, Cogdell D, Du X, Li H, Pang Y, Sun Y, Hu L, Sun B, Trent J, Chen K, Zhang W.

Technol Cancer Res Treat. 2010 Apr;9(2):161-9.


Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma.

Yang J, Cogdell D, Yang D, Hu L, Li H, Zheng H, Du X, Pang Y, Trent J, Chen K, Zhang W.

Cancer Lett. 2010 May 1;291(1):31-8. doi: 10.1016/j.canlet.2009.09.018. Epub 2009 Nov 6.


Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results.

Guo M, Lin CY, Gong Y, Cogdell DE, Zhang W, Lin E, Sneige N.

Mod Pathol. 2008 Aug;21(8):1037-43. doi: 10.1038/modpathol.2008.93. Epub 2008 May 23.


Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.

Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, Luthra R, Lin E, Lai HC, Zhang W, Sneige N.

J Clin Microbiol. 2008 Jan;46(1):274-80. Epub 2007 Oct 31.


Analysis of signaling pathways in 90 cancer cell lines by protein lysate array.

Mendes KN, Nicorici D, Cogdell D, Tabus I, Yli-Harja O, Guerra R, Hamilton SR, Zhang W.

J Proteome Res. 2007 Jul;6(7):2753-67. Epub 2007 Jun 12.


Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas.

Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I, Zhang W.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3414-9. Epub 2007 Feb 21.


Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma.

Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, Luthra R, Zhang W.

Mod Pathol. 2007 Feb;20(2):256-66. Epub 2006 Dec 22.


Dissection of signaling pathways in fourteen breast cancer cell lines using reverse-phase protein lysate microarray.

Akkiprik M, Nicorici D, Cogdell D, Jia YJ, Hategan A, Tabus I, Yli-Harja O, Y D, Sahin A, Zhang W.

Technol Cancer Res Treat. 2006 Dec;5(6):543-51.


Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.

Körbling M, Reuben JM, Gao H, Lee BN, Harris DM, Cogdell D, Giralt SA, Khouri IF, Saliba RM, Champlin RE, Zhang W, Estrov Z.

Transfusion. 2006 Oct;46(10):1795-802.


Transcriptional activation of the carboxylesterase 2 gene by the p53 pathway.

Choi W, Cogdell D, Feng Y, Hamilton SR, Zhang W.

Cancer Biol Ther. 2006 Nov;5(11):1450-6. Epub 2006 Nov 13.


Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.

Jiang R, Mircean C, Shmulevich I, Cogdell D, Jia Y, Tabus I, Aldape K, Sawaya R, Bruner JM, Fuller GN, Zhang W.

Proteomics. 2006 May;6(10):2964-71.


The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration.

McDonald JM, Dunlap S, Cogdell D, Dunmire V, Wei Q, Starzinski-Powitz A, Sawaya R, Bruner J, Fuller GN, Aldape K, Zhang W.

Cancer Biol Ther. 2006 Mar;5(3):300-4. Epub 2006 Mar 9.


Robust estimation of protein expression ratios with lysate microarray technology.

Mircean C, Shmulevich I, Cogdell D, Choi W, Jia Y, Tabus I, Hamilton SR, Zhang W.

Bioinformatics. 2005 May 1;21(9):1935-42. Epub 2005 Jan 12.


Improving signal intensities for genes with low-expression on oligonucleotide microarrays.

Ramdas L, Cogdell DE, Jia JY, Taylor EE, Dunmire VR, Hu L, Hamilton SR, Zhang W.

BMC Genomics. 2004 Jun 14;5(1):35.


Data extraction from composite oligonucleotide microarrays.

Shmulevich I, Astola J, Cogdell D, Hamilton SR, Zhang W.

Nucleic Acids Res. 2003 Apr 1;31(7):e36.


Monitoring of cDNA microarray with common primer target and hybridization specificity with selected targets.

Hu L, Cogdell DE, Jia YJ, Hamilton SR, Zhang W.

Biotechniques. 2002 Mar;32(3):528, 530-2, 534.


Comparative evaluation of laser-based microarray scanners.

Ramdas L, Wang J, Hu L, Cogdell D, Taylor E, Zhang W.

Biotechniques. 2001 Sep;31(3):546, 548, 550, passim.


Sequence verification as quality-control step for production of cDNA microarrays.

Taylor E, Cogdell D, Coombes K, Hu L, Ramdas L, Tabor A, Hamilton S, Zhang W.

Biotechniques. 2001 Jul;31(1):62-5.


AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.

Wildin RS, Cogdell DE, Valadez V.

Kidney Int. 1998 Dec;54(6):1909-22.


Identification of two classes of transcriptional regulator genes in the cyanobacterium Synechococcus sp. strain PCC 7942.

Anandan S, Nalty MS, Cogdell DE, Golden SS.

Arch Microbiol. 1996 Jul;166(1):58-63.


Supplemental Content

Loading ...
Support Center